| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 6.55e-07 | 11 | 136 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.95e-06 | 14 | 136 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 5.70e-06 | 38 | 136 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.13e-05 | 21 | 136 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 8.29e-05 | 152 | 136 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.14e-04 | 37 | 136 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.14e-04 | 37 | 136 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.27e-04 | 38 | 136 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.69e-04 | 46 | 136 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 4.38e-04 | 262 | 136 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | alkaline phosphatase activity | 6.78e-04 | 6 | 136 | 2 | GO:0004035 | |
| GeneOntologyMolecularFunction | sphingosine-1-phosphate phosphatase activity | 9.46e-04 | 7 | 136 | 2 | GO:0042392 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.33e-03 | 70 | 136 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 ERVK-7 ERVK-10 REV3L ARID1A DUS1L MLH3 SHPRH TRMT13 ERVK-11 QARS1 TDRD12 | 1.54e-03 | 645 | 136 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | dinucleotide phosphatase activity | 1.61e-03 | 9 | 136 | 2 | GO:0004551 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 1.61e-03 | 9 | 136 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 1.61e-03 | 9 | 136 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | actin binding | KIF18A SPATA31A3 SPATA31A7 FERMT1 SPATA31A5 PDLIM5 SPATA31A1 EGFR XIRP2 CTNNA3 | 1.66e-03 | 479 | 136 | 10 | GO:0003779 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 7.83e-07 | 48 | 138 | 6 | GO:0000731 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.31e-06 | 13 | 138 | 4 | GO:0015074 | |
| Domain | DUF4599 | 6.92e-05 | 12 | 130 | 3 | PF15371 | |
| Domain | DUF4599 | 6.92e-05 | 12 | 130 | 3 | IPR027970 | |
| Domain | CarboxyPept-like_regulatory | 2.09e-04 | 17 | 130 | 3 | IPR008969 | |
| Domain | HEAT | 3.44e-04 | 48 | 130 | 4 | PF02985 | |
| Domain | FerI | 4.74e-04 | 5 | 130 | 2 | SM01202 | |
| Domain | FerB | 4.74e-04 | 5 | 130 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 4.74e-04 | 5 | 130 | 2 | IPR012561 | |
| Domain | Ferlin_C | 4.74e-04 | 5 | 130 | 2 | PF16165 | |
| Domain | Ferlin_C | 4.74e-04 | 5 | 130 | 2 | IPR032362 | |
| Domain | FerIin_dom | 4.74e-04 | 5 | 130 | 2 | IPR012968 | |
| Domain | FerI | 4.74e-04 | 5 | 130 | 2 | PF08151 | |
| Domain | FerB | 4.74e-04 | 5 | 130 | 2 | PF08150 | |
| Domain | WxxW_domain | 7.08e-04 | 6 | 130 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 7.08e-04 | 6 | 130 | 2 | PF13330 | |
| Domain | HEAT | 7.11e-04 | 58 | 130 | 4 | IPR000357 | |
| Domain | TSP_1 | 9.72e-04 | 63 | 130 | 4 | PF00090 | |
| Domain | TSP1 | 1.09e-03 | 65 | 130 | 4 | SM00209 | |
| Domain | TSP1_rpt | 1.09e-03 | 65 | 130 | 4 | IPR000884 | |
| Domain | TSP1 | 1.09e-03 | 65 | 130 | 4 | PS50092 | |
| Domain | GPCR_3_mtglu_rcpt | 1.31e-03 | 8 | 130 | 2 | IPR000162 | |
| Domain | HEAT_REPEAT | 1.44e-03 | 70 | 130 | 4 | PS50077 | |
| Domain | cNMP | 1.68e-03 | 34 | 130 | 3 | SM00100 | |
| Domain | cNMP_binding | 1.68e-03 | 34 | 130 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 1.83e-03 | 35 | 130 | 3 | IPR000595 | |
| Domain | ATPase_P-typ_cyto_domN | 1.83e-03 | 35 | 130 | 3 | IPR023299 | |
| Domain | CNMP_BINDING_3 | 1.83e-03 | 35 | 130 | 3 | PS50042 | |
| Domain | ATPase_P-typ_P_site | 1.99e-03 | 36 | 130 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 1.99e-03 | 36 | 130 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.99e-03 | 36 | 130 | 3 | PS00154 | |
| Domain | PAS_9 | 2.09e-03 | 10 | 130 | 2 | PF13426 | |
| Domain | Hydrolase_3 | 2.09e-03 | 10 | 130 | 2 | PF08282 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.15e-03 | 37 | 130 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.15e-03 | 37 | 130 | 3 | PF00122 | |
| Domain | C2 | 2.24e-03 | 131 | 130 | 5 | PF00168 | |
| Domain | cNMP-bd-like | 2.33e-03 | 38 | 130 | 3 | IPR018490 | |
| Domain | PKD_channel | 2.54e-03 | 11 | 130 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 2.54e-03 | 11 | 130 | 2 | IPR013122 | |
| Domain | C2 | 2.72e-03 | 137 | 130 | 5 | SM00239 | |
| Domain | C-type_lectin-like | 3.06e-03 | 86 | 130 | 4 | IPR001304 | |
| Domain | C2 | 3.17e-03 | 142 | 130 | 5 | PS50004 | |
| Domain | Rossmann-like_a/b/a_fold | 3.32e-03 | 43 | 130 | 3 | IPR014729 | |
| Domain | - | 3.32e-03 | 43 | 130 | 3 | 3.40.50.620 | |
| Domain | Kinesin-like_fam | 3.32e-03 | 43 | 130 | 3 | IPR027640 | |
| Domain | - | 3.54e-03 | 44 | 130 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 3.54e-03 | 44 | 130 | 3 | PF00225 | |
| Domain | KISc | 3.54e-03 | 44 | 130 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 3.54e-03 | 44 | 130 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 3.54e-03 | 44 | 130 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 3.54e-03 | 44 | 130 | 3 | PS50067 | |
| Domain | NCD3G | 3.57e-03 | 13 | 130 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 3.57e-03 | 13 | 130 | 2 | IPR011500 | |
| Domain | - | 3.57e-03 | 13 | 130 | 2 | 2.10.10.10 | |
| Domain | - | 3.78e-03 | 148 | 130 | 5 | 2.60.40.150 | |
| Domain | FN_type2_col-bd | 4.14e-03 | 14 | 130 | 2 | IPR000562 | |
| Domain | FN2_2 | 4.14e-03 | 14 | 130 | 2 | PS51092 | |
| Domain | IMPORTIN_B_NT | 4.14e-03 | 14 | 130 | 2 | PS50166 | |
| Domain | FN2_1 | 4.14e-03 | 14 | 130 | 2 | PS00023 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 4.14e-03 | 14 | 130 | 2 | IPR003938 | |
| Domain | TUDOR | 4.14e-03 | 14 | 130 | 2 | PF00567 | |
| Domain | fn2 | 4.14e-03 | 14 | 130 | 2 | PF00040 | |
| Domain | GPCR_3_CS | 4.14e-03 | 14 | 130 | 2 | IPR017979 | |
| Domain | FN2 | 4.14e-03 | 14 | 130 | 2 | SM00059 | |
| Domain | - | 4.53e-03 | 48 | 130 | 3 | 2.60.120.10 | |
| Domain | - | 4.63e-03 | 222 | 130 | 6 | 1.25.10.10 | |
| Domain | IBN_N | 4.76e-03 | 15 | 130 | 2 | PF03810 | |
| Domain | RmlC-like_jellyroll | 5.38e-03 | 51 | 130 | 3 | IPR014710 | |
| Domain | IBN_N | 5.41e-03 | 16 | 130 | 2 | SM00913 | |
| Domain | ATPase_P-typ_TM_dom | 5.41e-03 | 16 | 130 | 2 | IPR023298 | |
| Domain | - | 5.41e-03 | 16 | 130 | 2 | 1.20.1110.10 | |
| Domain | C2_dom | 5.83e-03 | 164 | 130 | 5 | IPR000008 | |
| Domain | ATPase_P-typ_cation-transptr_C | 6.11e-03 | 17 | 130 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 6.11e-03 | 17 | 130 | 2 | PF00689 | |
| Domain | Importin-beta_N | 6.11e-03 | 17 | 130 | 2 | IPR001494 | |
| Domain | LH2 | 6.84e-03 | 18 | 130 | 2 | SM00308 | |
| Domain | Cation_ATPase_N | 6.84e-03 | 18 | 130 | 2 | PF00690 | |
| Domain | - | 6.84e-03 | 18 | 130 | 2 | 1.20.144.10 | |
| Domain | Cation_ATPase_N | 6.84e-03 | 18 | 130 | 2 | SM00831 | |
| Domain | acidPPc | 6.84e-03 | 18 | 130 | 2 | SM00014 | |
| Pubmed | 4.20e-09 | 6 | 144 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 4.20e-09 | 6 | 144 | 4 | 25930072 | |
| Pubmed | ATP8B3 DNAH10 MTHFD2 GRK6 KDM3B DNM1L RNF40 SEMA3G ARID1A GFPT1 KCNH3 KCNH6 EGFR FUT4 ATP4A WNK3 KIF11 | 1.08e-08 | 730 | 144 | 17 | 34857952 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MTA2 RAPGEF6 ABR KIF26A GRK6 KDM3B CBLC RNF40 REV3L ARID1A DUS1L KCNH3 MYOF IGF2R WIZ TULP4 LRP3 SNAPC4 HTT | 1.69e-07 | 1105 | 144 | 19 | 35748872 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 2.77e-07 | 4 | 144 | 3 | 10469592 | |
| Pubmed | 2.81e-06 | 24 | 144 | 4 | 32212159 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 31443490 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 21331365 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 28263981 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 24555532 | ||
| Pubmed | Mutant huntingtin regulates EGF receptor fate in non-neuronal cells lacking wild-type protein. | 1.70e-05 | 2 | 144 | 2 | 22974559 | |
| Pubmed | Transportin-mediated nuclear import of heterogeneous nuclear RNP proteins. | 1.70e-05 | 2 | 144 | 2 | 9298975 | |
| Pubmed | Scratch wound-induced CXCL8 upregulation is EGFR-dependent in keratinocytes. | 1.70e-05 | 2 | 144 | 2 | 32690371 | |
| Pubmed | Transportin-1 and Transportin-2: protein nuclear import and beyond. | 1.70e-05 | 2 | 144 | 2 | 24780099 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 30449600 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 27167200 | ||
| Pubmed | IL8 and EDEM3 gene expression ratio indicates peripheral blood mononuclear cell (PBMC) quality. | 1.70e-05 | 2 | 144 | 2 | 30496732 | |
| Pubmed | Kindlin-1 Regulates Epidermal Growth Factor Receptor Signaling. | 1.70e-05 | 2 | 144 | 2 | 30248333 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 21997870 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 37290638 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 25953375 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 31912442 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 21880736 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 21336284 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 29945960 | ||
| Pubmed | BANK negatively regulates Akt activation and subsequent B cell responses. | 1.70e-05 | 2 | 144 | 2 | 16546095 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 21831204 | ||
| Pubmed | EGF-induced centrosome separation promotes mitotic progression and cell survival. | 1.70e-05 | 2 | 144 | 2 | 23643362 | |
| Pubmed | Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans. | 1.70e-05 | 2 | 144 | 2 | 26071654 | |
| Pubmed | SIRT1 regulates TNF-α-induced expression of CD40 in 3T3-L1 adipocytes via NF-κB pathway. | 1.70e-05 | 2 | 144 | 2 | 22717288 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 16240219 | ||
| Pubmed | The cancer antigen CA125 represents a novel counter receptor for galectin-1. | 1.70e-05 | 2 | 144 | 2 | 12615972 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 21546588 | ||
| Pubmed | TNPO1 CTU2 KDM3B GATM DNM1L APOB GFPT1 LGALS1 EDEM3 MYOF IGF2R PLPP2 EGFR ASS1 QARS1 CLUH KIF11 | 2.81e-05 | 1297 | 144 | 17 | 33545068 | |
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 3.96e-05 | 91 | 144 | 5 | 34780483 | |
| Pubmed | 4.12e-05 | 222 | 144 | 7 | 37071664 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 4.63e-05 | 94 | 144 | 5 | 21542922 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 1971301 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 29427771 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 23012356 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 31260484 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 30026467 | ||
| Pubmed | SIRT1 Activation Attenuates Bone Cancer Pain by Inhibiting mGluR1/5. | 5.09e-05 | 3 | 144 | 2 | 31270711 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 34044070 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 30305725 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 29625788 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 32016961 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 17020928 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 20889674 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 9971820 | ||
| Pubmed | The C2 domains of otoferlin, dysferlin, and myoferlin alter the packing of lipid bilayers. | 5.09e-05 | 3 | 144 | 2 | 23859474 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 24894820 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 23977375 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 30381241 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 23603572 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 17918746 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 21544811 | ||
| Pubmed | ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. | 5.09e-05 | 3 | 144 | 2 | 20606625 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 18474653 | ||
| Pubmed | Involvement of transportin 2-mediated HuR import in muscle cell differentiation. | 5.09e-05 | 3 | 144 | 2 | 17475777 | |
| Pubmed | 5.42e-05 | 18 | 144 | 3 | 18664271 | ||
| Pubmed | 8.16e-05 | 55 | 144 | 4 | 31985874 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TNPO1 MTA2 NCAPD3 DNAH10 HSDL2 PCLO DNM1L APOB GRM1 GFPT1 IGF2R MRTO4 TDRD6 QARS1 ATP2B3 CLUH KIF11 | 8.95e-05 | 1425 | 144 | 17 | 30948266 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 9.32e-05 | 341 | 144 | 8 | 32971831 | |
| Pubmed | The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells. | 1.02e-04 | 4 | 144 | 2 | 15300588 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 10875935 | ||
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 25964092 | ||
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 21925169 | ||
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 19934275 | ||
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 22179316 | ||
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 16098254 | ||
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 12746903 | ||
| Pubmed | Karyopherin beta 2B participates in mRNA export from the nucleus. | 1.02e-04 | 4 | 144 | 2 | 12384575 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 10362357 | ||
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 37258409 | ||
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 16091361 | ||
| Pubmed | Molecular cloning and characterization of a novel cbl-family gene, cbl-c. | 1.02e-04 | 4 | 144 | 2 | 10571044 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 9079622 | ||
| Pubmed | Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes. | 1.02e-04 | 4 | 144 | 2 | 18369455 | |
| Pubmed | Conditional mutagenesis in mice with heat shock promoter-driven cre transgenes. | 1.02e-04 | 4 | 144 | 2 | 10723724 | |
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 29575122 | ||
| Pubmed | 1.02e-04 | 4 | 144 | 2 | 7983737 | ||
| Pubmed | Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR. | 1.02e-04 | 4 | 144 | 2 | 15037768 | |
| Pubmed | 1.48e-04 | 64 | 144 | 4 | 22261194 | ||
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 16289749 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.69e-04 | 5 | 144 | 2 | 11401426 | |
| Pubmed | Identification of disulfide-linked apolipoprotein species in human lipoproteins. | 1.69e-04 | 5 | 144 | 2 | 8245722 | |
| Pubmed | Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis. | 1.69e-04 | 5 | 144 | 2 | 24240174 | |
| Pubmed | MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1. | 1.69e-04 | 5 | 144 | 2 | 19819989 | |
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 29358589 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.69e-04 | 5 | 144 | 2 | 12629516 | |
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 15117950 | ||
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 19225046 | ||
| Pubmed | 1.69e-04 | 5 | 144 | 2 | 16687414 | ||
| Pubmed | MTA2 MTHFD2 CBX4 REV3L ARID1A SIRT1 EDEM3 MLH3 HMCN2 WIZ KMT5B ASS1 TCF25 TOPORS | 2.33e-04 | 1116 | 144 | 14 | 31753913 | |
| Pubmed | Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. | 2.53e-04 | 6 | 144 | 2 | 12692552 | |
| Pubmed | Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression. | 2.53e-04 | 6 | 144 | 2 | 1352323 | |
| Pubmed | 2.53e-04 | 6 | 144 | 2 | 32234475 | ||
| Pubmed | 2.53e-04 | 6 | 144 | 2 | 16788380 | ||
| Pubmed | 2.53e-04 | 6 | 144 | 2 | 10086340 | ||
| Cytoband | 9p13.1 | 5.95e-05 | 24 | 145 | 3 | 9p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 2.74e-04 | 8 | 145 | 2 | chr9q12 | |
| GeneFamily | Ferlin family | 3.79e-04 | 6 | 92 | 2 | 828 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 7.03e-04 | 8 | 92 | 2 | 281 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.65e-03 | 46 | 92 | 3 | 622 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_2_CELL | 2.73e-06 | 171 | 133 | 8 | M45687 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | TNPO1 CILP TNPO2 GRK6 GATM REV3L SIRT1 DUS1L EDEM3 MYOF WIZ FUT4 | 1.09e-05 | 506 | 133 | 12 | M253 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | NTF3 OLFML2B GATM MUC16 REV3L MYOF TENM4 EGFR EEPD1 ENPEP WNK3 | 2.54e-05 | 373 | 134 | 11 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | OLFML2B GATM MUC16 REV3L GFPT1 LGALS1 AKR1E2 MYOF IGF2R TENM4 EGFR EEPD1 ASS1 ENPEP WNK3 KIF11 | 3.03e-05 | 773 | 134 | 16 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | NTF3 OLFML2B GATM MUC16 LRRC4C THSD7B REV3L LGALS1 MYOF IGF2R TENM4 EGFR EEPD1 ASS1 ENPEP WNK3 | 3.22e-05 | 777 | 134 | 16 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.28e-07 | 149 | 138 | 7 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 176 | 138 | 7 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-06 | 183 | 138 | 7 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 138 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.96e-06 | 187 | 138 | 7 | 406ff9327d3109fe1e251629c4c617b00a573dc2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.18e-06 | 190 | 138 | 7 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | 18-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 2.59e-06 | 195 | 138 | 7 | e0ee7905499ee1a1ca7b1184e2713028cf156985 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.59e-06 | 195 | 138 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.59e-06 | 195 | 138 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 356C-Myeloid-Dendritic-cDC2|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-06 | 195 | 138 | 7 | 4c9a2167d8cfe40dfd609c303ada5b5ef800bd8f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-06 | 197 | 138 | 7 | cc494a656db868bb489238a5becc31bc8518f3cc | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 200 | 138 | 7 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.96e-06 | 155 | 138 | 6 | 335cd798afbaa0a3a3e1dc558a81cfa32da48983 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 1.04e-05 | 159 | 138 | 6 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-05 | 160 | 138 | 6 | 8374ae912337947b2cc8d17d5840f306361fe1ff | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 163 | 138 | 6 | a24db9d266a40f3bffe4f18d277bc269791b4560 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 172 | 138 | 6 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-05 | 173 | 138 | 6 | 5c55e1e27e9e3e77600d378cc87b51cc73907527 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.73e-05 | 174 | 138 | 6 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-05 | 177 | 138 | 6 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 177 | 138 | 6 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-05 | 177 | 138 | 6 | 4553ee8cd9c24db6511b09fe49ed11a89e7cde9e | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.09e-05 | 180 | 138 | 6 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.52e-05 | 186 | 138 | 6 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.67e-05 | 188 | 138 | 6 | c2321a3a1d9603f8b4b4fc09707eb32ec1e04f3f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-05 | 192 | 138 | 6 | dee97f650ae6f4d07a142ade402aae1905791a22 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 193 | 138 | 6 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.10e-05 | 193 | 138 | 6 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.10e-05 | 193 | 138 | 6 | 360079cbaa18b74e4a48c5de40844faca076e1a6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 193 | 138 | 6 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.19e-05 | 194 | 138 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-05 | 195 | 138 | 6 | 815ac5dacd382b11abb32011ed1c0635b0ddc779 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-S100A12-lo_cla._mono.|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.28e-05 | 195 | 138 | 6 | 66273af9882f829b6fc0e20f03f3412294d37c26 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.38e-05 | 196 | 138 | 6 | 624f700daea48d9bad4cc554f4776bd809ae1e54 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-05 | 197 | 138 | 6 | fd43fc1cbf0c17b370397d73dddc572565a759c7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-05 | 197 | 138 | 6 | 1c91e3afcc5be195b827a1dff83aff5cc2492456 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac|GI_small-bowel / Manually curated celltypes from each tissue | 3.67e-05 | 199 | 138 | 6 | 8990a3d69e24cb3aaba9d6def3d0be9ee973436d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-05 | 199 | 138 | 6 | f1723cfd6fbb8c8903a3b167872ec8523e3be250 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-05 | 199 | 138 | 6 | 6f5ef959b51eccf1ffc2e5ddf0d83c62ca2257b2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.67e-05 | 199 | 138 | 6 | 1aa99d21bf61b86df4a966dc47634044430aa39f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-05 | 199 | 138 | 6 | 83383d9ae4f501754fd3da0215ce6f0e3c70562c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.31e-05 | 130 | 138 | 5 | a3e12984fb61311e49cc76c59f74f4dffc48faa1 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 7.30e-05 | 139 | 138 | 5 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 9.21e-05 | 146 | 138 | 5 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | Club_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 9.51e-05 | 147 | 138 | 5 | 5a824c89e4d045af465d7333275f8191fb29b041 | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage-macrophage_-_intermediate_-_unactivated|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.05e-04 | 150 | 138 | 5 | 60fdd266aaca1b589b9a77465a4a7fad4921339a | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.11e-04 | 152 | 138 | 5 | 0769857f25da2e6169420818e61d65e33b7277b1 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.22e-04 | 155 | 138 | 5 | 9d53caee196b5c2bbc90c4f54f693b64d4086065 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.26e-04 | 156 | 138 | 5 | 2cd007b423c2395c5ce331902e7f27c805755eb3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 158 | 138 | 5 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 158 | 138 | 5 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.37e-04 | 159 | 138 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 160 | 138 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 160 | 138 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 161 | 138 | 5 | c61283c301a87bb802f6f8ce79c26067032dd7d9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 161 | 138 | 5 | 9864d8b0929dacf4be7a4e97d2527ac3120ea264 | |
| ToppCell | Club_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.59e-04 | 164 | 138 | 5 | 4e25e6362ef793b08de2f4d1dccb6b1fc9c072a5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 167 | 138 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 168 | 138 | 5 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 2.04e-04 | 173 | 138 | 5 | 38f88f5bbf92a3bf5109bc4782cd071b7cb1ca34 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-04 | 174 | 138 | 5 | 778e0317c0c63fa4efd74114feb760975b819d92 | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.09e-04 | 174 | 138 | 5 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-04 | 174 | 138 | 5 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1-3_PAX6_NABP1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 175 | 138 | 5 | f7f8c16e81b26748a5323d70c542d06c02eccdff | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-04 | 175 | 138 | 5 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-04 | 175 | 138 | 5 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 176 | 138 | 5 | 5f9ae5eb45603ed0422a3a993ecdbe2ce05d6e45 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-04 | 176 | 138 | 5 | 8b5c2fb7e5e551df658b1d5fc7f607a27bab00d5 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 176 | 138 | 5 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 178 | 138 | 5 | 5cf12927f0756c4d8a289fe4308d736382e6212e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.32e-04 | 178 | 138 | 5 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_THTPA|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 178 | 138 | 5 | e4e11e4940c911c17806200c25096928153c684d | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 179 | 138 | 5 | 4f20540bfbcefe0e83812be7ea542e8bb3bf19bc | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-04 | 179 | 138 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 179 | 138 | 5 | d78eacf47847a50888dd16c35bed9b7afc80010f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-04 | 179 | 138 | 5 | 5bf191bdc0c32bce83ab5c38f0616e209e420e55 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-04 | 180 | 138 | 5 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.45e-04 | 180 | 138 | 5 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.45e-04 | 180 | 138 | 5 | 7085a851807e6a833965e1366946db0bbc5174e2 | |
| ToppCell | severe_influenza-B_memory|severe_influenza / disease group, cell group and cell class (v2) | 2.51e-04 | 181 | 138 | 5 | 92e572c92109a6dae0f73138c57c3bbd2e0a2f36 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.51e-04 | 181 | 138 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 2.51e-04 | 181 | 138 | 5 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-04 | 182 | 138 | 5 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 182 | 138 | 5 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 182 | 138 | 5 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.57e-04 | 182 | 138 | 5 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-04 | 182 | 138 | 5 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.57e-04 | 182 | 138 | 5 | c3fb1460160744144aa31afc76c0a4d42ebdeb91 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.57e-04 | 182 | 138 | 5 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 2.64e-04 | 183 | 138 | 5 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.64e-04 | 183 | 138 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-04 | 183 | 138 | 5 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.64e-04 | 183 | 138 | 5 | 4cc0961a67de76b8d756cd9ffcaa98e3fe3c3a69 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 2.64e-04 | 183 | 138 | 5 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 7.01e-07 | 291 | 130 | 10 | EFO_0008317, EFO_0020946 | |
| Disease | apolipoprotein B measurement | DCHS2 SP4 DNAH10 GRK6 CBLC APOB PKD1L3 ARID1A MYOF CILP2 IGF2R PSORS1C1 HTT | 7.81e-06 | 663 | 130 | 13 | EFO_0004615 |
| Disease | intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (implicated_via_orthology) | 1.93e-05 | 2 | 130 | 2 | DOID:0081262 (implicated_via_orthology) | |
| Disease | risk-taking behaviour | KIF26A LRRC4C THSD7B REV3L PKD1L3 RNF227 KIRREL3 TENM4 TULP4 PSORS1C1 CD40 BANK1 HTT | 3.45e-05 | 764 | 130 | 13 | EFO_0008579 |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 5.28e-05 | 91 | 130 | 5 | EFO_0004611, EFO_0005271 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 9.52e-05 | 103 | 130 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | familial hyperlipidemia | 1.09e-04 | 106 | 130 | 5 | MONDO_0001336 | |
| Disease | high density lipoprotein particle size measurement | 1.11e-04 | 170 | 130 | 6 | EFO_0008592 | |
| Disease | Insulin Resistance | 1.45e-04 | 60 | 130 | 4 | C0021655 | |
| Disease | Insulin Sensitivity | 1.45e-04 | 60 | 130 | 4 | C0920563 | |
| Disease | cholesteryl ester measurement | 1.49e-04 | 257 | 130 | 7 | EFO_0010351 | |
| Disease | Behcet Syndrome | 1.58e-04 | 24 | 130 | 3 | C0004943 | |
| Disease | Lumbar disc disease | 1.91e-04 | 5 | 130 | 2 | C0221775 | |
| Disease | INTERVERTEBRAL DISC DISEASE | 1.91e-04 | 5 | 130 | 2 | 603932 | |
| Disease | Intervertebral disc disorder | 1.91e-04 | 5 | 130 | 2 | cv:C0158252 | |
| Disease | cholesterol in large VLDL measurement | 1.98e-04 | 65 | 130 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 1.98e-04 | 65 | 130 | 4 | EFO_0022230 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 2.02e-04 | 26 | 130 | 3 | OBA_2045191 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | CTTNBP2 KIF26A LRRC4C THSD7B REV3L RNF227 TENM4 TULP4 CD40 CTNNA3 HPS5 CACNA2D3 | 2.28e-04 | 801 | 130 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | triglycerides to phosphoglycerides ratio | 2.35e-04 | 68 | 130 | 4 | EFO_0022327 | |
| Disease | Streptococcal pneumonia | 2.86e-04 | 6 | 130 | 2 | C0155862 | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 2.86e-04 | 6 | 130 | 2 | DOID:13809 (is_marker_for) | |
| Disease | Intervertebral disc disorder | 2.86e-04 | 6 | 130 | 2 | C0158252 | |
| Disease | Endometrial Carcinoma | 2.93e-04 | 72 | 130 | 4 | C0476089 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 3.89e-04 | 301 | 130 | 7 | DOID:684 (is_marker_for) | |
| Disease | LDL cholesterol change measurement | 3.99e-04 | 7 | 130 | 2 | EFO_0007804 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 3.99e-04 | 7 | 130 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Liver carcinoma | 4.27e-04 | 507 | 130 | 9 | C2239176 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.88e-04 | 224 | 130 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 5.00e-04 | 225 | 130 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | Familial hypercholesterolemia | 5.30e-04 | 8 | 130 | 2 | cv:C0020445 | |
| Disease | serum metabolite measurement | TNPO1 GRK6 PKD1L1 GATM APOB REV3L C2orf78 GTF2B IGF2R KMT5B HPS5 ENPEP | 9.86e-04 | 945 | 130 | 12 | EFO_0005653 |
| Disease | Unipolar Depression | 1.04e-03 | 259 | 130 | 6 | C0041696 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.15e-03 | 264 | 130 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | Osteosarcoma | 1.18e-03 | 47 | 130 | 3 | C0029463 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.27e-03 | 181 | 130 | 5 | DOID:684 (is_implicated_in) | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 1.31e-03 | 107 | 130 | 4 | EFO_0004614, EFO_0004615 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 1.41e-03 | 50 | 130 | 3 | EFO_0022247 | |
| Disease | Alzheimer disease | 1.42e-03 | 485 | 130 | 8 | MONDO_0004975 | |
| Disease | Hyperlipoproteinemia Type IIb | 1.46e-03 | 13 | 130 | 2 | C1704417 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.76e-03 | 195 | 130 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | triglycerides in medium VLDL measurement | 1.85e-03 | 55 | 130 | 3 | EFO_0022155 | |
| Disease | phospholipids in medium HDL measurement | 1.85e-03 | 55 | 130 | 3 | EFO_0022295 | |
| Disease | triglycerides in large VLDL measurement | 1.95e-03 | 56 | 130 | 3 | EFO_0022178 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.96e-03 | 200 | 130 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | lymphocyte count | THEMIS2 TNPO1 DNAH10 PCDHGB2 CHML GTF2B CILP2 CCDC66 TENM4 PLPP2 EGFR CRLF3 CD40 CLEC16A HTT | 2.02e-03 | 1464 | 130 | 15 | EFO_0004587 |
| Disease | pre-eclampsia (is_marker_for) | 2.16e-03 | 58 | 130 | 3 | DOID:10591 (is_marker_for) | |
| Disease | Endometrial Neoplasms | 2.16e-03 | 58 | 130 | 3 | C0014170 | |
| Disease | Obesity | 2.19e-03 | 205 | 130 | 5 | C0028754 | |
| Disease | Hyperlipoproteinemia Type IIa | 2.22e-03 | 16 | 130 | 2 | C0745103 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.30e-03 | 303 | 130 | 6 | EFO_0004612, EFO_0020945 | |
| Disease | total lipids in VLDL measurement | 2.38e-03 | 60 | 130 | 3 | EFO_0022314 | |
| Disease | cholesterol to total lipids in IDL percentage | 2.38e-03 | 60 | 130 | 3 | EFO_0022233 | |
| Disease | triglycerides in small VLDL measurement | 2.50e-03 | 61 | 130 | 3 | EFO_0022145 | |
| Disease | acute kidney failure (biomarker_via_orthology) | 2.50e-03 | 61 | 130 | 3 | DOID:3021 (biomarker_via_orthology) | |
| Disease | free cholesterol in very large VLDL measurement | 2.50e-03 | 61 | 130 | 3 | EFO_0022274 | |
| Disease | phospholipids in large VLDL measurement | 2.61e-03 | 62 | 130 | 3 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 2.61e-03 | 62 | 130 | 3 | EFO_0022322 | |
| Disease | total lipids in very large VLDL measurement | 2.61e-03 | 62 | 130 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 2.61e-03 | 62 | 130 | 3 | EFO_0022299 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.69e-03 | 215 | 130 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.78e-03 | 315 | 130 | 6 | EFO_0004612, EFO_0008591 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 2.78e-03 | 315 | 130 | 6 | EFO_0004574, EFO_0004612 | |
| Disease | behavior or behavioral disorder measurement, personality trait | 2.81e-03 | 18 | 130 | 2 | EFO_0004365, EFO_0004782 | |
| Disease | Hypercholesterolemia, Familial | 2.81e-03 | 18 | 130 | 2 | C0020445 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 3.06e-03 | 321 | 130 | 6 | EFO_0004612, EFO_0004639 | |
| Disease | total lipids in very large HDL measurement | 3.12e-03 | 66 | 130 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 3.12e-03 | 66 | 130 | 3 | EFO_0022298 | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 3.13e-03 | 136 | 130 | 4 | DOID:9352 (is_marker_for) | |
| Disease | Down Syndrome, Partial Trisomy 21 | 3.14e-03 | 19 | 130 | 2 | C0432416 | |
| Disease | Trisomy 21, Meiotic Nondisjunction | 3.14e-03 | 19 | 130 | 2 | C0432417 | |
| Disease | Trisomy 21, Mitotic Nondisjunction | 3.14e-03 | 19 | 130 | 2 | C0751081 | |
| Disease | Down Syndrome | 3.14e-03 | 19 | 130 | 2 | C0013080 | |
| Disease | Systemic Scleroderma | 3.14e-03 | 19 | 130 | 2 | C0036421 | |
| Disease | reasoning | 3.14e-03 | 19 | 130 | 2 | EFO_0004350 | |
| Disease | total lipids in small VLDL | 3.26e-03 | 67 | 130 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 3.26e-03 | 67 | 130 | 3 | EFO_0022175 | |
| Disease | Grand Mal Status Epilepticus | 3.26e-03 | 67 | 130 | 3 | C0311335 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 3.26e-03 | 67 | 130 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | radiation-induced disorder | 3.26e-03 | 67 | 130 | 3 | EFO_0009565 | |
| Disease | Status Epilepticus, Subclinical | 3.26e-03 | 67 | 130 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 3.26e-03 | 67 | 130 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 3.26e-03 | 67 | 130 | 3 | C0751523 | |
| Disease | Petit mal status | 3.26e-03 | 67 | 130 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 3.26e-03 | 67 | 130 | 3 | C0393734 | |
| Disease | phospholipids:total lipids ratio | 3.39e-03 | 227 | 130 | 5 | EFO_0020946 | |
| Disease | Status Epilepticus | 3.40e-03 | 68 | 130 | 3 | C0038220 | |
| Disease | free cholesterol in large VLDL measurement | 3.40e-03 | 68 | 130 | 3 | EFO_0022265 | |
| Disease | metabolite measurement | 3.45e-03 | 560 | 130 | 8 | EFO_0004725 | |
| Disease | atherosclerosis (biomarker_via_orthology) | 3.47e-03 | 20 | 130 | 2 | DOID:1936 (biomarker_via_orthology) | |
| Disease | citrulline measurement | 3.47e-03 | 20 | 130 | 2 | EFO_0009777 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 3.50e-03 | 330 | 130 | 6 | EFO_0004529, EFO_0004612 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.52e-03 | 229 | 130 | 5 | EFO_0004639, EFO_0008317 | |
| Disease | cholesterol in very large HDL measurement | 3.54e-03 | 69 | 130 | 3 | EFO_0022229 | |
| Disease | ST2 protein measurement | 3.83e-03 | 21 | 130 | 2 | EFO_0010599 | |
| Disease | gestational age, birth measurement | 3.83e-03 | 21 | 130 | 2 | EFO_0005112, EFO_0006921 | |
| Disease | skin hydration measurement | 3.83e-03 | 21 | 130 | 2 | EFO_0009586 | |
| Disease | Colorectal Carcinoma | 3.99e-03 | 702 | 130 | 9 | C0009402 | |
| Disease | triglycerides to total lipids in small HDL percentage | 3.99e-03 | 72 | 130 | 3 | EFO_0022336 | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 3.99e-03 | 72 | 130 | 3 | DOID:9744 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PYIVRQCVEEVEKRG | 661 | Q12979 | |
| QLRDCIIGKRPEEEN | 721 | Q8NDB2 | |
| EIQPCLAESRAAREK | 886 | O75150 | |
| RVKQCPGSLREEEIA | 586 | Q5SNV9 | |
| PGKEASEQRIRELCG | 516 | Q14050 | |
| LEGALVRRQAKEPCV | 16 | P02652 | |
| KNPECLLEREVVVGS | 521 | A6NCI8 | |
| EVQERLQACRDKPGS | 246 | Q9ULV8 | |
| PVARKLSAREQRDCE | 631 | O00429 | |
| EKLNLRGCEVVPDVN | 416 | Q9BQL6 | |
| RGCEVVPDVNVAGRK | 421 | Q9BQL6 | |
| RCQEEISRQEGAKPT | 311 | Q6P1R4 | |
| CVGDVVCLRKDNIVP | 236 | O60423 | |
| GDVDIPRAKVVRVCQ | 86 | Q96QD5 | |
| CSVEKANNPGVREVV | 271 | Q7L9B9 | |
| EVPEAIRKCQRAGIT | 686 | Q16720 | |
| PCIARKQVEIAQREG | 96 | P00966 | |
| LAFREGKVEQVPCSR | 266 | P26374 | |
| EIRVGCKYQAEIPDR | 146 | O94776 | |
| NRCADLTAVDPVRGK | 211 | Q7Z3H0 | |
| NGEDEKCRSFRSVVP | 101 | A8MUP6 | |
| GKLGEQCEAVVRFPR | 36 | Q9NVH2 | |
| KGDLIGCELPRREQV | 641 | Q9ULD8 | |
| GCELPRREQVVKANA | 646 | Q9ULD8 | |
| DVVERLREKCSPGGV | 576 | Q9HCC9 | |
| RRIQQAVESCPEEKG | 1181 | Q8N1W1 | |
| DPFVVDCSDKLGRVQ | 1821 | O14497 | |
| RPEKDGAATRVDAVC | 13381 | Q8WXI7 | |
| LAIIAREGDCAPEEK | 206 | P43357 | |
| NLKPGECLRVRGEVA | 11 | P09382 | |
| ECLRVRGEVAPDAKS | 16 | P09382 | |
| CNILKTEGVTVRRPD | 131 | P50440 | |
| RVCQAVQRAGDRPKS | 506 | P22083 | |
| KAVAGRPVALECVAR | 1636 | Q8NDA2 | |
| VAIPHNRRKECGQED | 751 | Q8NI77 | |
| VECDPVRKEVSVRTG | 41 | P52732 | |
| DIKNGRIEICNIEAP | 301 | Q9Y234 | |
| RDTACVKALRDIEPG | 286 | Q4FZB7 | |
| NVVDKSCPRGIIRVE | 551 | Q9BZQ6 | |
| LKVRPELRGDEQSCE | 566 | Q9UPZ3 | |
| FRCLVDVVPVKNEDG | 106 | Q9H252 | |
| DEKPVDLTAGRRAVC | 2926 | Q9Y6V0 | |
| VGKVPLCFVEREANE | 1301 | Q9UHC1 | |
| VSDRIDREQICGKQP | 86 | Q9Y5G2 | |
| QPDRRDSIGVCAEKQ | 326 | Q8IUI8 | |
| GCPGEDVERAQKLRD | 61 | Q4VXF1 | |
| DVERAQKLRDCPGED | 66 | Q4VXF1 | |
| ELKGCPQEDVERVQR | 106 | Q4VXF1 | |
| FEIICKRLRSEDGQP | 1466 | Q7LBC6 | |
| VDKDRKVCREPLVDG | 696 | O75074 | |
| GKALPCIVDVRDEQQ | 66 | Q6YN16 | |
| GCEVAARAARRPEAV | 1286 | Q9ULI4 | |
| EALQLVKEGRVPCRT | 321 | Q7L4E1 | |
| ICVRKNLREVPDGIS | 61 | Q9HCJ2 | |
| ELKRPSGDQVQVRRC | 146 | Q07075 | |
| APECGRCQRKILGEV | 476 | Q96HC4 | |
| LEKVCRGNPADVTEA | 146 | O43688 | |
| KEARPVKNGCRGIDD | 196 | P20783 | |
| CKGGPDEDAVERQRR | 6 | P0C7M6 | |
| VGRALQPVREKFSDC | 176 | P63135 | |
| VGRALQPVREKFSDC | 176 | Q9BXR3 | |
| ELKGCPQEDVERVQR | 106 | A6NL05 | |
| REDAQPGAEVCRVRA | 306 | Q6V1P9 | |
| EDIVEVQGSPRCKIC | 96 | Q9Y2Y8 | |
| AGPELQADCDQIVKR | 841 | Q460N5 | |
| RCRPINATLAVEKEG | 26 | Q6NT52 | |
| REKPEETCAAVRRGS | 861 | Q9UI47 | |
| VDKCNLLEGEPREFV | 536 | P00533 | |
| ERDLGQCDRFKPIRT | 206 | P04114 | |
| VTRRKGRCVEPETAN | 326 | Q8NBI3 | |
| KCDQGQADPVVAVAR | 941 | P42858 | |
| RTVDPEQARGVLKCD | 731 | O15303 | |
| PDENGVIAFDCRNRK | 231 | Q8IZS8 | |
| GGLEPERRDKCNRTV | 936 | Q8WZ74 | |
| EPIDLRCVKTRSEAG | 471 | O00257 | |
| GQKRQLFDSDCVRDP | 881 | A2RUB6 | |
| EDAGKYVCRAVVPRV | 391 | Q8IZU9 | |
| EVTPDDKRKACGRQL | 91 | P43250 | |
| RDEKDGINRCLPDGQ | 131 | Q13255 | |
| TGDPKRIDDVLCRVD | 496 | Q8IVF4 | |
| VIKVDFCADQPRIVD | 201 | Q6ZTR5 | |
| IPDCAGEVEKVLAAR | 2236 | Q8TDX9 | |
| VPVDQVNRKDARACV | 661 | P20648 | |
| CKEAQPVVVIRAGDA | 31 | Q2VPK5 | |
| CKEGDVLTPEQARVL | 176 | Q9UKD2 | |
| AQVDRPRVDIECAGK | 1151 | Q9HC10 | |
| DGQIIKRVCGNERPA | 191 | Q6UXH9 | |
| RSQGPEIVEVEKGCR | 491 | P22897 | |
| RVLQEGKARGCPEDA | 521 | P11717 | |
| ACPVVRVEGDNCEVK | 1216 | P11717 | |
| AAPREEQEKLGDICF | 231 | O00445 | |
| LEVTCRRADAGEKPK | 661 | P47897 | |
| ERIARKGEQCNIVPD | 406 | Q9HCB6 | |
| DQEVQPGKRLRRVAC | 611 | Q02446 | |
| GAAEEEDARKRILCP | 46 | Q9NUP7 | |
| CEVSVTPEGVIKQRR | 796 | Q8TEU7 | |
| RLVDFGNIEDCVDPK | 1601 | O60522 | |
| QVVARQGRPVVICDK | 626 | Q06210 | |
| ERRICNAVSPDKDVD | 141 | P13995 | |
| AVEFIVCRVKPADNE | 996 | Q587J7 | |
| SKAGETREAVPQCRV | 946 | Q8IWB4 | |
| GDCELDRVFIPVSKR | 851 | Q7Z443 | |
| DPQKVARFQRLCGVE | 16 | Q9BX95 | |
| EKARAKCERDEAGNP | 106 | A6NIN4 | |
| CICGELDQIDRKPRV | 661 | Q149N8 | |
| EAVRGDIFNQVVPRC | 381 | Q96EB6 | |
| KQVPGDEGREARLQC | 341 | O95785 | |
| PQDKLEVREGAEIRC | 356 | Q6P1J6 | |
| NPCEGDFRLQKLREA | 126 | Q68BL8 | |
| PEEEDDIRNVIGRCK | 481 | Q68BL8 | |
| SCEGVDLIDNPVIKR | 226 | Q96JD6 | |
| DQDPRTAKEIALGRC | 1081 | O75339 | |
| DQSPRLAKEIAIGRC | 1066 | Q8IUL8 | |
| GDIAQLCPARVEKRI | 861 | P42695 | |
| IAFKRAEAVEPDGCV | 21 | Q8N812 | |
| PCGDVEKTRRAIRVF | 656 | Q2KHT3 | |
| LTKRGRQVCADPSEE | 66 | P16619 | |
| DPRSREVIRNACKAV | 691 | O75153 | |
| VGRALQPVREKFSDC | 176 | P63136 | |
| EKIPELARGDVCTAR | 466 | A4UGR9 | |
| SKAGETREAVPQCRV | 946 | Q5VYP0 | |
| LRAKGETCPRQVDNR | 71 | A6NLX4 | |
| PRAAGELEEAKCRRA | 1436 | Q9NRJ4 | |
| TLLEQGKEPCVVARD | 56 | Q8NDQ6 | |
| GKEPCVVARDVTGRQ | 61 | Q8NDQ6 | |
| DAKGIETVRRDSCPA | 2851 | O60673 | |
| SKAGETREAVPQCRV | 946 | Q5TZJ5 | |
| SKAGETREAVPQCRV | 946 | Q5VU36 | |
| VCERARQGCEPILIK | 111 | Q92765 | |
| IACRQEGVPRTFKEI | 166 | Q00403 | |
| LAVDDDPEVRKNVCR | 221 | O14787 | |
| PLRVVATKDCEGERE | 346 | Q5TEJ8 | |
| VGRALQPVREKFSDC | 176 | P10266 | |
| DDCRKGRTQEDILVP | 76 | Q9UIG5 | |
| VGRALQPVREKFSDC | 176 | Q9UQG0 | |
| KDIVPQEAEEFCRTG | 61 | Q6N022 | |
| VTKRGQDVALRCDPI | 31 | A0A1B0GX31 | |
| VTKRGQDVTLRCDPI | 31 | A0A0K0K1E9 | |
| LAGDEEPEVRKNVCR | 231 | Q92973 | |
| DNCVIVGFVKPLAER | 476 | Q9NS56 | |
| KQPRVACDVEVDGVR | 3931 | Q7Z7G8 | |
| KIREEVPGRSDAQCR | 426 | Q5SXM2 | |
| QREECVRKGRDPLTE | 101 | Q9NS98 | |
| VRKGRDPLTECANFV | 106 | Q9NS98 | |
| RGEVKPRTAECVTAQ | 121 | Q9C0I4 | |
| DRGALVAINPGDRKC | 151 | P51580 | |
| ADLEEVVRVCPGFKA | 371 | Q5TAA0 | |
| DAGDPAVEACENRRK | 531 | Q9BQ70 | |
| VAKRGQDVALRCDPI | 31 | A0A1B0GX51 | |
| KTDVVCGPQDRLRAL | 181 | P25942 | |
| RCQEREFGLEIPQKE | 96 | Q9Y473 | |
| EKKPAGCLEERRDSQ | 496 | Q9BYP7 | |
| EGAVLPRSAKELRCQ | 21 | P10145 | |
| KPVVGQCTIERLDRF | 1386 | Q9NZM1 |